SecBot SecBot
SECBOTREPLAY Home › Report › KALV

KALV · Two C-suite insiders, the CEO and CMO of KalVista, made nominal…

KalVista Pharmaceuticals, Inc. · CLUSTER filed May 19, 2026 at 16:04 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed May 19, 2026 at 16:04 ET

Two C-suite insiders, the CEO and CMO of KalVista, made nominal open-market sales totaling $58K (-0.004% of $1.4B market cap) on May 18, 2026, alongside option exercises. The dollar value is immaterial relative to market cap, and the sales follow a derivative exercise pattern consistent with routine tax- or vesting-related liquidation rather than informed selling.

  • CEO Palleiko sold 1,129 shares ($30K) on May 18 at $26.76
  • CMO Audhya sold 1,032 shares ($28K) on May 18 at $26.76
  • Both insiders had exercised 2,419 derivative shares at $0 on May 17 (non-cash)
  • Total open-market sales = $58K, or ~0.004% of $1.4B market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access